ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2250

Contribution of Personality Traits, Psychological Factors and Health Related Quality of Life on Medication Adherence in Patients with RA

Kyung Min Ko1, Su-Jin Moon 2, Jung Hee Koh 1 and Jun-Ki Min 1, 1Division of Rheumatology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Bucheon, Republic of Korea, 2Division of Rheumatology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Uijeongbu, Republic of Korea

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Compliance and Health Assessment Questionnaire, Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Patient Outcomes, Preferences, & Attitudes Poster II: Patient Preferences, Beliefs, & Experiences

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Non-adherence to long-term treatment is important in Rheumatoid arthritis (RA), as it can result in inadequate disease control and make rheumatologist to change the treatment strategy. Personality refers to individual differences in characteristic pattern of thinking, feeling and behaving. However, it is not clear that personality could predict medication non-adherence in patients with RA. The aim of this study is to investigate the association between personality traits and medication adherence and to identify the predictors of good medication adherence in RA patients including personality traits, psychosocial factors, disease activity, pain and health related quality of life (HRQoL).

Methods: Total 207 RA patients using disease-modifying antirheumatic drugs (DMARDs) was invited for an interview and questionnaire study from rheumatology outpatient clinics in Bucheon St. Mary’s hospital in Korea. Medication adherence was measured with the Compliance Questionnaire of Rheumatology (CQR). Personality traits was analyzed with the five-factor model (neuroticism, extraversion, openness to experience, agreeableness, and conscientiousness) with Korean version of Big Five Inventory 10 (K-BFI-10). A high level of each personality trait represents high scores (≧4 average score) of each personality item of five factor models. Psychological factors were also assessed with Patient Health Questionnaire (PHQ-9), General Anxiety Disorder 7(GAD-7) and the British Columbia Cognitive Inventory (BC-CCI), respectively. HRQoL and functional disability were evaluated with EuroQoL dimension (EQ5D) and health associated quality (HAQ). Multivariate logistic regression analyses were performed to investigate predictors of good medication adherence.

Results: A total of 207 RA patients (Female 83.1%, mean age 57 years, mean RA duration, 8.0 years) were participated. Non adherence to their DMARD prescription (CQR < 80) was reported in 66.2%. The number of daily prescribed pills was higher in the medication adherence group (P = 0.03). Concomitant oral glucocorticoids use and the dose was significantly associated with medication adherence. The personality trait, high level of conscientiousness and comorbid with diabetes mellitus were associated with better medication adherence (odds ratio [OR], 2.37; 95% confidence interval [CI, 1.24-4.53 and OR,2.57; 95% CI, 1.03-6.42, respectively) (Table 1). There were no significant differences in psychological factors and HRQoL between medication adherence and nonadherence group.

Conclusion: The personality traits were associated with medication adherence; conscientiousness was a predictor of medication adherence, among the five personality traits. Patients with diabetes mellitus showed higher medication adherence.


Disclosure: K. Ko, None; S. Moon, None; J. Koh, None; J. Min, None.

To cite this abstract in AMA style:

Ko K, Moon S, Koh J, Min J. Contribution of Personality Traits, Psychological Factors and Health Related Quality of Life on Medication Adherence in Patients with RA [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/contribution-of-personality-traits-psychological-factors-and-health-related-quality-of-life-on-medication-adherence-in-patients-with-ra/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/contribution-of-personality-traits-psychological-factors-and-health-related-quality-of-life-on-medication-adherence-in-patients-with-ra/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology